We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

183 hedge funds and large institutions have $1.62B invested in Cardiovascular Systems, Inc. in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 74 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $2.92M | Put options by funds: $2.21M

13% more capital invested

Capital invested by funds: $1.43B → $1.62B (+$185M)

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

2% less funds holding

Funds holding: 186183 (-3)

20% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 74

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
183
Holders Change
-3
Holders Change %
-1.61%
% of All Funds
3.22%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
22
Increased
59
Reduced
74
Closed
24
Calls
$2.92M
Puts
$2.21M
Net Calls
+$705K
Net Calls Change
-$2.06M

CSII Hedge Fund Activity: Q4 2020 in Review

183 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2020, worth a combined $1.62B — up 13% from $1.43B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CSII and 22 opened new positions — a net loss of 2 holders — while 74 trimmed existing stakes and 59 added.

The largest buyer was RGM Capital, adding an estimated $31.8M. The largest seller was Citadel Advisors, cutting an estimated $16.7M.

  • 183 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2020, down from 186 in Q3 2020.
  • Funds reported $1.62B of Cardiovascular Systems, Inc. stock for Q4 2020, up 13% quarter-over-quarter.
  • 22 funds opened new Cardiovascular Systems, Inc. positions in Q4 2020 and 24 closed out, a net change of -2 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2020 was RGM Capital, an estimated $31.8M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2020 was Citadel Advisors, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2020.